NovaBay Pharma (NBY) Misses Q1 EPS by 32c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Research and development: 4K
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Research and development: 4K
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q1 EPS of ($0.85), $0.32 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $3.12 million versus the consensus estimate of $5.45 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and memory not a classic bubble, but future returns uncertain - strategist
- Bernstein SocGen's Thoughts on McDonald's (MCD) Following Investor Day
- Wells Fargo Starts Dover Corp. (DOV) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
